Driehaus Capital Management LLC

Position in CLYM — Climb Bio, Inc.

CIK 938206 Chicago, IL

Position in CLYM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,301,600

+$6,185,120 QoQ

Shares Held

790,000

+31.5% QoQ

Ownership

1.38%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#18

of 108 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,602,052,293 across 59 Biotechnology names. CLYM ranks #43 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	6,845,276	$322,001,783
2	PRAX	Praxis Precision Medicines, Inc.	959,048	$321,079,679
3	XENE	Xenon Pharmaceuticals Inc.	4,418,557	$266,704,100
4	SYRE	Spyre Therapeutics, Inc.	2,799,166	$248,509,957
5	CRNX	Crinetics Pharmaceuticals, Inc.	6,463,551	$241,866,078
6	APGE	Apogee Therapeutics, Inc.	1,740,101	$230,963,605
7	EWTX	Edgewise Therapeutics, Inc.	4,728,623	$192,123,952
8	SEPN	Septerna, Inc.	4,433,058	$148,463,112

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,301,600	790,000	+31.5%	Shares	Sole	2026-08-14
2026-03-31	$4,116,480	600,946	0.0%	Shares	Sole	2026-05-15
2025-12-31	$2,403,784	600,946	-1.9%	Shares	Sole	2026-02-17
2024-09-30	$3,117,049	612,387	-12.0%	Shares	Sole	2024-11-14
2024-06-30	$4,948,965	696,057	-14.2%	Shares	Sole	2024-08-15
2024-03-31	$2,224,003	811,680	0.0%	Shares	Sole	2024-05-15
2023-12-31	$2,191,536	811,680	0.0%	Shares	Sole	2024-02-14
2023-09-30	$2,134,718	811,680	+0.1%	Shares	Sole	2023-11-14
2023-06-30	$2,269,660	810,593	+20.3%	Shares	Sole	2023-08-14
2023-03-31	$1,953,683	673,684	+22.1%	Shares	Sole	2023-05-15
2022-12-31	$2,025,627	551,942	+58.3%	Shares	Sole	2023-02-14
2022-09-30	$1,125,884	348,571	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.